Publication: A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa).
dc.contributor.author | Chianese, Giuseppina | |
dc.contributor.author | Sirignano, Carmina | |
dc.contributor.author | Benetti, Emanuele | |
dc.contributor.author | Marzaroli, Vittoria | |
dc.contributor.author | Collado, Juan A | |
dc.contributor.author | de la Vega, Lauren | |
dc.contributor.author | Appendino, Giovanni | |
dc.contributor.author | Muñoz, Eduardo | |
dc.contributor.author | Taglialatela-Scafati, Orazio | |
dc.contributor.funder | MIUR | |
dc.date.accessioned | 2023-05-03T15:22:57Z | |
dc.date.available | 2023-05-03T15:22:57Z | |
dc.date.issued | 2022-03-22 | |
dc.description.abstract | A phytochemical analysis of mother liquors obtained from crystallization of CBD from hemp (Cannabis sativa), guided by LC-MS/MS and molecular networking profiling and completed by isolation and NMR-based characterization of constituents, resulted in the identification of 13 phytocannabinoids. Among them, anhydrocannabimovone (5), isolated for the first time as a natural product, and three new hydroxylated CBD analogues (1,2-dihydroxycannabidiol, 6, 3,4-dehydro-1,2-dihydroxycannabidiol, 7, and hexocannabitriol, 8) were obtained. Hexocannabitriol (8) potently modulated, in a ROS-independent way, the Nrf2 pathway, outperforming all other cannabinoids obtained in this study and qualifying as a potential new chemopreventive chemotype against cancer and other degenerative diseases. | |
dc.description.sponsorship | This research was funded by MIUR, research grant PRIN2017, Project WN73PL (Bioactivity-directed exploration of the phytocannabinoid chemical space). LC-MS experiments were run at the LAS (Laboratorio di Analisi Strumentale). The assistance of Dr. Chiara Cassiano is acknowledged. O.T.S. thanks Indena SpA for financial support. | |
dc.identifier.citation | Chianese G, Sirignano C, Benetti E, Marzaroli V, Collado JA, de la Vega L, et al. A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa). J Nat Prod. 2022 Apr 22;85(4):1089-1097 | |
dc.identifier.doi | 10.1021/acs.jnatprod.1c01198 | |
dc.identifier.essn | 1520-6025 | |
dc.identifier.pmc | PMC9040056 | |
dc.identifier.pmid | 35316044 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040056/pdf | |
dc.identifier.unpaywallURL | https://discovery.dundee.ac.uk/files/74584444/acs.jnatprod.1c01198.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/22593 | |
dc.issue.number | 4 | |
dc.journal.title | Journal of natural products | |
dc.journal.titleabbreviation | J Nat Prod | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Instituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC | |
dc.page.number | 1089-1097 | |
dc.publisher | American Chemical Society | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.relation.projectID | PRIN2017 | |
dc.relation.publisherversion | https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c01198 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Cannabidiol | |
dc.subject | Cannabinoids | |
dc.subject | Cannabis | |
dc.subject | NF-E2-related factor 2 | |
dc.subject.decs | Cromatografía liquida | |
dc.subject.decs | Espectrometría de masas en tándem | |
dc.subject.decs | Cromatografía liquida | |
dc.subject.decs | Especies reactivas de oxígeno | |
dc.subject.mesh | Chromatography, liquid | |
dc.subject.mesh | Tandem mass spectrometry | |
dc.subject.mesh | Reactive oxygen species | |
dc.subject.mesh | Liquid chromatography-mass spectrometry | |
dc.subject.mesh | Chromatography, liquid | |
dc.title | A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa). | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 85 | |
dspace.entity.type | Publication |